Articles published by Aqualung Therapeutics
Aqualung Therapeutics Appoints Two New Board Directors; Will Attend June 22 Bio Meeting in San Diego
June 08, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Preclinical studies show Aqualung Therapeutic’s eNAMPT- targeting ALT-100 mAb to reduce severity of aggressive prostate cancer
January 25, 2022
Via AccessWire
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|